SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada)
Stephen G. Noorduyn, Christina Qian, Karissa M. Johnston, Mena Soliman, Manisha Talukdar, Brandie L. Walker, Paul Hernandez, Erika Penz
ERJ Open Research 2022; DOI: 10.1183/23120541.00140-2022
Stephen G. Noorduyn
1Department of Medical Affairs, AstraZeneca Canada, Mississauga, Canada
2Department of Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Canada
Christina Qian
3Broadstreet HEOR, Vancouver, Canada
Karissa M. Johnston
3Broadstreet HEOR, Vancouver, Canada
4Memorial University, St. John's, Canada
Mena Soliman
1Department of Medical Affairs, AstraZeneca Canada, Mississauga, Canada
Manisha Talukdar
1Department of Medical Affairs, AstraZeneca Canada, Mississauga, Canada
Brandie L. Walker
5Division of Respirology, Department of Medicine, University of Calgary, Calgary, Canada
Paul Hernandez
6Division of Respirology, Department of Medicine, Dalhousie University, Halifax, Canada
Erika Penz
7Division of Respirology, Critical Care and Sleep Medicine, University of Saskatchewan, Saskatoon, Canada
Vol 9 Issue 2
Table of Contents
SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada)
Stephen G. Noorduyn, Christina Qian, Karissa M. Johnston, Mena Soliman, Manisha Talukdar, Brandie L. Walker, Paul Hernandez, Erika Penz
ERJ Open Research Jan 2022, 00140-2022; DOI: 10.1183/23120541.00140-2022
SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada)
Stephen G. Noorduyn, Christina Qian, Karissa M. Johnston, Mena Soliman, Manisha Talukdar, Brandie L. Walker, Paul Hernandez, Erika Penz
ERJ Open Research Jan 2022, 00140-2022; DOI: 10.1183/23120541.00140-2022